Quantitative assessment of changes in carotid plaques during cilostazol administration using three-dimensional ultrasonography and non-gated magnetic resonance plaque imaging

Neuroradiology

Volumn 54, Issue 9, 2012, Pages 939-945

  Yamaguchi, Mao ^a   Sasaki, Makoto ^a   Ohba, Hideki ^a   Mori, Kiyofumi ^a   Narumi, Shinsuke ^a   Katsura, Noriyuki ^a   Ohura, Kazumasa ^a   Kudo, Kohsuke ^a   Terayama, Yasuo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Carotid stenosis; Cilostazol; Magnetic resonance imaging; Plaque imaging; Ultrasonography

Indexed keywords

CILOSTAZOL; LIPID;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN SIZE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAYSCALE MEDIAN; HUMAN; HUMAN TISSUE; MALE; NONGATED MAGNETIC RESONANCE PLAQUE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PLAQUE VOLUME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; TREATMENT DURATION;

AGED; CAROTID STENOSIS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; TETRAZOLES; TREATMENT OUTCOME;

EID: 84863938043     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-012-1011-2     Document Type: Article

References (20)

1. Uchiyama S, Demaerschalk BM, Goto S, Shinohara Y, Gotoh F, Stone WM, Money SR, Kwon SU (2009) Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis 18(6):482-490. doi:10.1016/j.jstrokecerebrovasdis.2009. 07.010
2. Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C (2010) Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomized non-inferiority trial. Lancet Neurol 9:959-968. doi:10.1016/S1474-4422(10)70198- 8
3. Katakami N, Kim YS, Kawamori R, Yamasaki Y (2010) The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation 121:2584-2591. doi:10.1161/CIRCULATIONAHA.109.892414
4. Takeda M, Yamashita T, Shinohara M, Sasaki N, Tawa H, Nakajima K, Momose A, Hirata KI (2011) Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phasecontrast X-ray CT imaging. Int J Cardiovasc Imaging. doi:10.1007/ s10554-011-9910-6
5. Lee JH, Oh GT, Park SY, Choi JH, Park JG, Kim CD, Lee WS, Rhim BY, Shin YW, Hong KW (2005) Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factoralpha formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Pharmacol Exp Ther 313:502-509 (Pubitemid 40604148)
6. Nakaya K, Ayaori M, Uto-Kondo H, Hisada T, Ogura M, Yakushiji E, Takiguchi S, Terao Y, Ozasa H, Sasaki M, Komatsu T, Ohsuzu F, Ikewaki K (2010) Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo. Atherosclerosis 213:135-141. doi:10.1016/j.atherosclerosis.2010.07.024
7. Iba T, Kidokoro A, FukunagaM, Takuhiro K, Ouchi M, Ito Y (2006) Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock 26:522-526. doi:10.1097/01.shk.0000228800.56223.db (Pubitemid 44632284)
8. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, Kasayama S (2001) Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence. Atherosclerosis 158:121-128 (Pubitemid 32735475)
9. Kwon SU, ChoYJ, Koo JS, BaeHJ, LeeYS, Hong KS, Lee JH,Kim JS (2005) Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebocontrolled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36:782-786. doi:10.1161/01.STR.0000157667.06542.b7
10. Pipe JG (1999) Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn Reson Med 42:963-969 (Pubitemid 29521487)
11. Narumi S, Sasaki M, Ohba H, Ogasawara K, Hitomi J, Mori K, Ohura K, Ono A, Terayama Y (2010) Altered carotid plaque signal among different repetition times on T1-weighted magnetic resonance plaque imaging with self-navigated radial-scan technique. Neuroradiology 52:285-290. doi:10.1007/s00234-009-0642-4
12. Sabetai MM, Tegos TJ, Nicolaides AN, Dhanjil S, Pare GJ, Stevens JM (2000) Reproducibility of computer-quantified carotid plaque echogenicity: can we overcome the subjectivity? Stroke 31:2189-2196
13. Sztajzel R, Momjian-Mayor I, Comelli M, Momjian S (2006) Correlation of cerebrovascular symptoms and microembolic signals with the stratified gray-scale median analysis and color mapping of the carotid plaque. Stroke 37:824-829. doi:10.1161/01. STR.0000204277.86466.f0 (Pubitemid 43731916)
14. Makris GC, Lavida A, Nicolaides AN, Geroulakos G (2010) The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis 213:8-20. doi:10.1016/j. atherosclerosis.2010.04.032
15. Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS (2006) Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI - initial results. Stroke 37:818-823. doi:10.1161/01. STR.0000204638.91099.91 (Pubitemid 43731915)
16. Yoshida K, Narumi O, Chin M, Inoue K, Tabuchi T, Oda K, Nagayama M, Egawa N, Hojo M, Goto Y, Watanabe Y, Yamagata S (2008) Characterization of carotid atherosclerosis and detection of soft plaque with use of black-blood MR imaging. AJNR Am J Neuroradiol 29:868-874. doi:10.3174/ajnr.A1015 (Pubitemid 351684958)
17. Vicenzini E, Giannoni MF, Puccinelli F, Ricciardi MC, Altieri M, Di Piero V, Gossetti B, Valentini FB, Lenzi GL (2007) Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke 38:2841- 2843. doi:10.1161/STROKEAHA.107.48791818 (Pubitemid 47494026)
18. Unger EC, Cohen MS, Brown TR (1989) Gradient-echo imaging of hemorrhage at 1.5 Tesla. Magn Reson Imaging 7:163-172 (Pubitemid 19114366)
19. Lee YS, Kwon ST, Kim JO, Choi ES (2011) Serial MR imaging of intramuscular hematoma: experimental study in a rat model with the pathologic correlation. Korean J Radiol 12:66-77. doi:10.3348/kjr.2011.12.1.66
20. Kullmer K, Sievers KW, Rompe JD, Nagele M, Harland U (1997) Sonography and MRI of experimental muscle injuries. Arch Orthop Trauma Surg 116:357-361 (Pubitemid 27351164)